Salesforce (CRM) shares dropped over 4% in premarket trading on Thursday after both Bernstein and KeyBanc Capital Markets downgraded the stock, attributing their concerns to the underperformance of the Agentforce AI product. The shares fell to approximately $159, down from a previous close of $166.58.

Why This Matters

The downgrade highlights significant challenges Salesforce faces in executing its AI strategy, which could impact the company's market position and future growth. Firms like Bernstein emphasized the struggles in gaining customer trust and adoption for the Agentforce product, which is critical for Salesforce's AI ambitions.

  • Salesforce shares traded at around $159 after the downgrade.
  • The company's stock has lost 37% of its value this year.
  • More CIOs anticipate reducing Salesforce budget allocations within the next year than those who plan to increase spending.

KeyBanc analyst Jackson Ader expressed skepticism about the stock's growth potential, noting a lack of supporting data from recent customer events suggesting that client data is inadequately organized for effective AI implementation. He remarked that the Agentforce product does not meet expectations and has only recently started showing promise in pipeline deals.

Bernstein conducted a CIO survey revealing that Salesforce was perceived negatively within the IT budgetary landscape, causing concern. More CIOs plan to deprioritize spending on Salesforce compared to those contemplating increases. This trend raises serious questions about the company's marketing strategy and its capability to persuade customers on the value of its AI offerings.

Looking Ahead

Investors and analysts should monitor Salesforce's upcoming quarterly results for insights into its response to these challenges. The company’s ability to address the highlighted concerns about Agentforce and regain confidence among CIOs will be crucial in the coming months. Questions regarding its strategic focus on AI and product enhancements also remain open.

This material is for informational purposes only and is not financial advice.